- Health
- SEE MORE
- classical
- general
- talk
- News
- Family
- Bürgerfunk
- pop
- Islam
- soul
- jazz
- Comedy
- humor
- wissenschaft
- opera
- baroque
- gesellschaft
- theater
- Local
- alternative
- electro
- rock
- rap
- lifestyle
- Music
- como
- RNE
- ballads
- greek
- Buddhism
- deportes
- christian
- Technology
- piano
- djs
- Dance
- dutch
- flamenco
- social
- hope
- christian rock
- academia
- afrique
- Business
- musique
- ελληνική-μουσική
- religion
- World radio
- Zarzuela
- travel
- World
- NFL
- media
- Art
- public
- Sports
- Gospel
- st.
- baptist
- Leisure
- Kids & Family
- musical
- club
- Culture
- Health & Fitness
- True Crime
- Fiction
- children
- Society & Culture
- TV & Film
- gold
- kunst
- música
- gay
- Natural
- a
- francais
- bach
- economics
- kultur
- evangelical
- tech
- Opinion
- Government
- gaming
- College
- technik
- History
- Jesus
- radio
- movies
- services
- Church
- podcast
- Education
- international
- Transportation
- Other
- kids
- podcasts
- philadelphia
- Noticias
- love
- sport
- Salud
- film
- and
- 4chan
- Disco
- Stories
- fashion
- Arts
- interviews
- hardstyle
- entertainment
- humour
- medieval
- literature
- alma
- Cultura
- video
- TV
- Science
- en
Treating Hypoxia and Low Oxygen with Drug Compound Trans-Sodium Crocetinate Derived from Saffron with Dr. Robert Cobuzzi Diffusion Pharmaceuticals
Dr. Robert Cobuzzi, CEO, Diffusion Pharmaceuticals describes the evolution of the thinking about treating hypoxia and low oxygen conditions caused by a variety of diseases and conditions. With modified crocetin derived from the spice saffron harvested from Crocus sativus, Diffusion has come up with a compound Trans-Sodium Crocetinate --TSC--to treat hypoxic conditions related to peripheral artery disease, blockages of peripheral arteries, brain cancer and other types of solid tumors, strokes and respiratory diseases like COVID-19.
@diffusionpharma #crocetinate #TSC #hypoxia #hypoxic #lowoxygen #COVID19
